DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Depin JC, Vigié A, Chavernac G, Rousselot C, Lardy C, Guerrier D.
Pharmacodynamics and antithrombotic effects after intravenous administration of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Arzneimittelforschung 1994;
44 (11) 1203-1207
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.